DENVER, Nov. 20, 2018 /PRNewswire/ -- At a recent international ENT Conference in London, UK Dr. Dave Singh, President and Chief Medical Officer of Vivos Therapeutics, presented pioneering findings regarding the long-term clinical implications of utilizing the Vivos System, garnering a very positive response from attendees. Vivos Therapeutics is a leading company focused on addressing the root causes of mild-to-moderate sleep apnea, advocating a non-surgical treatment as a potentially permanent solution.
The large, international audience consisted of renowned otolaryngologists—head and neck surgeons. Dr. Singh's paper, entitled Non-surgical improvement of the upper airway for sleep disordered breathing: 5 year follow up, described the treatment of a 56-year-old male patient diagnosed with sleep apnea. Treatment consisted of 18 months of using the Vivos Therapeutic System. In a 5.5-year follow-up after initial use of a Vivos System oral appliance, the upper airway volume was shown to have increased significantly and its cross-sectional area had also increased dramatically. In other words, no relapse or regression in the size, shape, or function of the airway towards pre-treatment conditions was detected.
"The results of this particular case-study serve to further underline the results possible from utilizing the Vivos System of proprietary biomimetic oral appliances and corresponding protocols," said Dr. Singh. "From this, we conclude that the Vivos System may be able to non-surgically enhance the upper airway in adult patients diagnosed with sleep disordered breathing."
"In our mission to rid the world of the life-threatening condition known as obstructive sleep apnea, it is essential to reach the wide array of health care professionals involved in treating issues related to obstructive sleep apnea," said Vivos CEO Kirk Huntsman. "We look forward to continue to sharing research and results with doctors around the world."
ABOUT VIVOS
Headquartered in Denver Colorado, Vivos Therapeutics Inc. is a company that provides training for dentists and health care providers, allowing them to integrate breathing wellness into their practice. The Vivos System is a proprietary, non-invasive, non-surgical treatment protocol, administered by a multidisciplinary team of highly-trained health care professionals. This revolutionary technology represents the first hope for a lasting solution to the problem of sleep apnea. Vivos Therapeutics has over 850 Certified and Integrated Providers throughout the US and two Canadian Provinces. For more information, please visit https://www.vivoslife.com/.
Media Contact:
Mollie Wagoner
Live Wire Media Relations, LLC
(703) 519-1600 Ext. 106
mwagoner@livewiredc.com
SOURCE Vivos Therapeutics
